FINEOS (FCL) investor relations material

Strategic and financial performance

• Revenues nearly doubled since IPO, with North America now contributing over 80% of total revenue, reinforcing market leadership and commercial momentum.

• Subscription fees as a share of revenue rose from 39.2% in CY21 to 54.6% in FY25, with a target of 65% by FY27, driven by up-sell, cross-sell, and new client acquisition.

• Achieved positive free cash flow (€6.4m) and net profit (€1.0m) in FY25, with EBITDA margin improving from 15.2% (FY24) to 21.9% (FY25).

• R&D investment efficiency improved, dropping from 37% of revenue in FY24 to 34.7% in FY25, targeting 30% by FY27.

• Guidance for FY27–FY29 includes gross margins of 75–80% and EBITDA margins rising from 25% to 40%.

Product and technology innovation

• Transitioned from a claims-only solution to a cloud-native, end-to-end employee benefits platform, integrating acquisitions and expanding product suite.

• Embedded AI capabilities recognized with the 2025 Technology Ireland Innovation Award, enhancing triage, summarization, and document understanding.

• AI-driven automation and AWS investments enable faster deployment, scalable growth, and improved operational efficiency.

• AI assistants and agents are embedded in process moments, supporting both client-facing and internal productivity improvements.

• Platform supports secure, explainable, and insurer-controlled AI, with industry-specific models for life, accident, and health.

Operational efficiency and scalability

• Platform workload has grown 5.4x (API) and 2.8x (user) since Jan 2023, while infrastructure costs per environment have dropped by 37%.

• Leaner infrastructure, serverless architecture, and AWS cost optimization have reduced total infrastructure costs by 14% since Jan 2023.

• Resource management strategies include transition to lower-cost regions and expanded use of flexible partners.

• Standardization, productization, and externalization drive greater customer autonomy and operational efficiency.

• Platform proven at scale, supporting over 2.5 million annual 'life event' cases and $40B+ in cumulative payments projected by 2026.